Hubble Therapeutics

About:

Hubble Therapeutics is a biotechnology research company that offers gene therapy for leber congenital amaurosis type 16.

Description:

Total Funding Amount:

$9.81M

Headquarters Location:

Hanover, New Hampshire, United States

Founded Date:

2000-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-10-21

IPO Status:

Private

Industries: